Cargando…
Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514182/ https://www.ncbi.nlm.nih.gov/pubmed/37735162 http://dx.doi.org/10.1038/s41467-023-41662-3 |
| _version_ | 1785108673678278656 |
|---|---|
| author | Patterson, Andrew Auslander, Noam |
| author_facet | Patterson, Andrew Auslander, Noam |
| author_sort | Patterson, Andrew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10514182 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105141822023-09-23 Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma Patterson, Andrew Auslander, Noam Nat Commun Author Correction Nature Publishing Group UK 2023-09-21 /pmc/articles/PMC10514182/ /pubmed/37735162 http://dx.doi.org/10.1038/s41467-023-41662-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Patterson, Andrew Auslander, Noam Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma |
| title | Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma |
| title_full | Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma |
| title_fullStr | Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma |
| title_full_unstemmed | Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma |
| title_short | Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma |
| title_sort | author correction: mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514182/ https://www.ncbi.nlm.nih.gov/pubmed/37735162 http://dx.doi.org/10.1038/s41467-023-41662-3 |
| work_keys_str_mv | AT pattersonandrew authorcorrectionmutatedprocessespredictimmunecheckpointinhibitortherapybenefitinmetastaticmelanoma AT auslandernoam authorcorrectionmutatedprocessespredictimmunecheckpointinhibitortherapybenefitinmetastaticmelanoma |